Quick Specifications

Vial Size 15MG
BAC Water 1ML
Amount Per Unit 0.15MG PER UNIT
Recommended Dose 1.5MG TO 4.5MG (10 TO 30 UNITS)
Frequency 5 DAYS ON 2 OFF
Injection Type SUBCUTANEOUS
Timing Fasted - 45 Minutes Before and After Injection

Research Overview

BEST BLEND FOR OVERALL BODY AND ANTI-AGING MIXED WITH HEAVY WEIGHT LOSS NEEDS

How It Works

Stabilized GHRH Analogue

Tesamorelin is a stabilized synthetic form of full-length GHRH (44 amino acids) modified with a trans-3-hexenoic acid group. This modification increases stability and extends bioavailability compared to native GHRH, while maintaining the same receptor binding profile.

Visceral Fat Reduction

Clinical trials in HIV-associated lipodystrophy — where tesamorelin is FDA-approved — demonstrated specific visceral adipose tissue (VAT) reduction averaging 15–18% over 26 weeks. The mechanism involves GH-mediated lipolysis preferentially targeting visceral fat depots.

GHRH + GHRP Synergy

When combined with ipamorelin, tesamorelin activates both GHRH receptors (increasing GH synthesis) and ghrelin receptors (increasing GH release), producing greater combined GH secretion than either peptide alone through complementary mechanisms.

Commonly Studied With

These peptides are frequently researched alongside 2X Blend: Tesamorelin (10mg) / Ipamorelin (5mg) due to complementary mechanisms:

Research & Educational Purposes Only

2X Blend: Tesamorelin (10mg) / Ipamorelin (5mg) information on this page is for research and educational purposes only. This content is not FDA-approved, does not constitute medical advice, and should not be used to guide personal health decisions. Consult a qualified healthcare professional before using any research compound.

Dose Calculator

Enter your target dose to calculate the volume to draw.

in mcg

Recommended dose: 1.5MG TO 4.5MG (10 TO 30 UNITS)